What is Transcat's options canceled (in dollars per share)?

Transcat (TRNS) reported options canceled (in dollars per share) of $0.00 in Q2 2025.

Transcat TRNS Options canceled (in dollars per share)

Options canceled (in dollars per share) at other companies

Ondas, Inc. ONDS

$5.42+274%

XylemXYL

$127.87+13.3%

Oruka Therapeutics, Inc.ORKA

$15.04—

Avanos MedicalAVNS

$31.83-14.8%

Playtika Holding Corp.PLTK

$16.65-12.0%

Bicara TherapeuticsBCAX

$0.00—

Other financials

Income statement

See full

Revenue$89.3M+15.8%

Gross profit$30.5M+17.6%

Operating income$4.3M-37.6%

Net income$1.9M-56.4%

EPS (diluted)$0.20-58.3%

Balance sheet

See full

Cash & equivalents$4.9M+226%

Total debt$133.6M+131%

Total equity$300.6M+4.8%

Total assets$480.5M+24.7%

Cash flow

See full

Operating cash flow$6.2M-41.7%

CapEx$3.6M+33.2%

Free cash flow$2.6M-67.1%

Valuation

See full

Market cap$858.22M+14.4%

Enterprise value$986.87M+22.3%

P/E159.6×+108×

P/S2.6×-0.1×

Profitability

See full

Gross margin32.6%+0.5pp

Operating margin4%-2.4pp

Net margin1.6%-3.6pp

FCF margin5.9%-3.4pp

Returns & leverage

See full

Return on equity1.8%-3.8pp

Debt / equity0.4×+0.2×

Current ratio2.3×0.0×

Where this comes from

Reported directly by Transcat in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.

The official record: Transcat’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Transcat's options canceled (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Transcat's options canceled (in dollars per share)?: Transcat (TRNS) reported options canceled (in dollars per share) of $0.00 in Q2 2025.